momelotinib dihydrochloride

1 Drug classified under this active ingredient

Kinase Inhibitor. momelotinib dihydrochloride 100 mg, 150 mg, 200 mg.
FC Tab  30 X 100,150,200 mg
Daily dose: 200 mg. Not to be used with other JAK inhib. CBC  and liver function to be tested before and during tmt.
Tmt. of intermediate or high-risk myelofibrosis (MF), including prim. MF or sec. MF [post-polycythemia vera (PV) and post-essential thrombocythemia (ET)], in adults with anemia.
C/I:  Hypersens. Pregn. and lactat